Hotelbuchung
Hotel Registration
Grußwort
Welcome address
Beteiligte Gesellschaften
Societies involved
DOG Information
DOG Information
Eröffnung des Kongresses
Opening Ceremony
Preise
Awards
Ablauf der Tagung 2003
General overview of congress
Lageplan der Räumlichkeiten
Map of Congress Center
Wissenschaftliche Themen
Scientific topics
Symposien
Symposia
Wissenschaftliches Programm
Scientific program
Posterpräsentationen
Poster Presentation
Kurse
Courses
Begleitende Veranstaltungen
Accompanying program
Arbeitssitzungen
Working sessions
Rahmenprogramm
Social program
Allgemeine Informationen
General Information
Autorenindex
Index of Authors
Industrieaussteller
Commercial exhibitors
Sponsoren
Sponsors
Impressum
DOG Homepage
Abstract
Abstract
Evidence-based Indications for PDT outside the TAP and VIP Trial
Bunse A.
Klinik für Ophthalmologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel
In the treatment of Age-related Maculadegeneration (AMD) Photodynamic Therapy (PDT) with Verteporfin is established. The two multicenter trials TAP (Treatment of Age-related Maculadegeneration with Photodynamic Therapy) and VIP (Verteporfin in Photodynamic Therapy) show a significant stabilisation of visual function following PDT-treatment compared to a placebo-treated group of patients. These effects are evident for classic and occult choroidal neovascularisations (CNV) of AMD. The therapeutic mechanism of PDT can be used to treat other diseases of the central retina such as Angoid streaks and POHS. In addition choroidal Hemangiomas can be treated by PDT. This contribution discusses indications for PDT-treatment outside the TAP and VIP trials. Recent publications and examples will be demonstrated.